Literature DB >> 1864542

Amenorrhoea in women with non-alcoholic chronic liver disease.

T F Cundy1, J Butler, R M Pope, A K Saggar-Malik, M J Wheeler, R Williams.   

Abstract

Amenorrhoea is common in women with non-alcoholic chronic liver disease, but little is known about its causes or consequences. We investigated 12 young women with non-alcoholic chronic liver disease and amenorrhoea and compared them with 11 healthy age matched controls studied in the follicular phase of the menstrual cycle. None of the patients had raised serum concentrations of follicle stimulating hormone suggesting primary gonadal failure, but the variance in serum concentrations of testosterone, oestradiol, prolactin, and luteinising hormone were significantly greater in chronic liver disease patients than control subjects (p less than 0.01). Seven of the 12 chronic liver disease patients had low serum luteinising hormone concentrations, and compared with controls these patients also had significantly reduced median values of oestradiol (64 pmol/l), testosterone (1.1 nmol/l), and follicle stimulating hormone, and were significantly underweight as assessed by skinfold thickness measurements (all comparisons p less than 0.025). In the group with chronic liver disease skinfold thickness was significantly correlated with serum luteinising hormone (p less than 0.02). The five patients with normal serum luteinising hormone had higher median values of both oestradiol (237 pmol/l) and testosterone (3.0 nmol/l) than the control subjects (oestradiol: 113 pmol/l, testosterone: 1.9 nmol/l) but were not more obese or hirsute. Amenorrhoea was unrelated to the duration or severity of liver disease. The metacarpal cortical bone area (an index of bone density) was inversely related to the duration of amenorrhoea (p less than 0.02). We conclude that amenorrhoea in women with non-alcoholic chronic liver disease arises from hypothalamic-pituitary dysfunction and can occur at any stage. The hormonal findings in amenorrhoeic chronic live disease patients are not uniform. In some, hypogonadotrophic hypogonadism is related to undernutrition whereas others have normal to high values of luteinising hormone and sex steroids. Prolonged oestrogen deficiency can be a risk factor for osteoporosis in women with chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864542      PMCID: PMC1378809          DOI: 10.1136/gut.32.2.202

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Hypogonadism in chronic liver disease: impaired release of luteinising hormone.

Authors:  P Bannister; T Handley; C Chapman; M S Losowsky
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-08

Review 2.  Pathogenesis and treatment of steroid osteoporosis.

Authors:  I R Reid
Journal:  Clin Endocrinol (Oxf)       Date:  1989-01       Impact factor: 3.478

3.  Hypogonadism in alcoholic liver disease: evidence for a double defect.

Authors:  D H Van Thiel; R Lester; R J Sherins
Journal:  Gastroenterology       Date:  1974-12       Impact factor: 22.682

Review 4.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

5.  Liver disease and the hypothalamic pituitary gonadal axis.

Authors:  D H Van Thiel; J S Gavaler; R R Schade
Journal:  Semin Liver Dis       Date:  1985-02       Impact factor: 6.115

6.  Plasma free testosterone--is an index sufficient?

Authors:  M N Nanjee; M J Wheeler
Journal:  Ann Clin Biochem       Date:  1985-07       Impact factor: 2.057

7.  Hypogonadism and sexual dysfunction in hemochromatosis: the effects of cirrhosis and diabetes.

Authors:  T Cundy; A Bomford; J Butler; M Wheeler; R Williams
Journal:  J Clin Endocrinol Metab       Date:  1989-07       Impact factor: 5.958

8.  Plasma concentrations of sex hormones in postmenopausal women in non-alcoholic cirrhosis.

Authors:  P Bannister; P Sheridan; M S Losowsky
Journal:  Clin Endocrinol (Oxf)       Date:  1985-10       Impact factor: 3.478

9.  Recovery of menstruation and pregnancy after liver transplantation.

Authors:  T F Cundy; J G O'Grady; R Williams
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

10.  The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women.

Authors:  R A Lobo; D Shoupe; P Serafini; D Brinton; R Horton
Journal:  Fertil Steril       Date:  1985-02       Impact factor: 7.329

View more
  8 in total

1.  Hepatobiliary Quiz Answers - 18 (2016).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2016-07-25

Review 2.  Pregnancy following liver transplantation: review of outcomes and recommendations for management.

Authors:  Kuljit S Parhar; Paul S Gibson; Carla S Coffin
Journal:  Can J Gastroenterol       Date:  2012-09       Impact factor: 3.522

3.  Management and outcome of pregnancy in autoimmune hepatitis.

Authors:  M A Heneghan; S M Norris; J G O'Grady; P M Harrison; I G McFarlane
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

4.  Pregnancy and its outcome in patients with noncirrhotic portal hypertension.

Authors:  R Kochhar; S Kumar; R C Goel; P V Sriram; M K Goenka; K Singh
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

5.  Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes.

Authors:  Annsa C Huang; Joshua Grab; Jennifer A Flemming; Jennifer L Dodge; Roxanna A Irani; Monika Sarkar
Journal:  Am J Gastroenterol       Date:  2022-03-01       Impact factor: 12.045

6.  Outcomes of Pregnancy in Mothers With Cirrhosis: A National Population-Based Cohort Study of 1.3 Million Pregnancies.

Authors:  Hannes Hagström; Jonas Höijer; Hanns-Ulrich Marschall; Catherine Williamson; Michael A Heneghan; Rachel H Westbrook; Jonas F Ludvigsson; Olof Stephansson
Journal:  Hepatol Commun       Date:  2018-09-25

Review 7.  Clinical Implications of Thrombocytopenia for the Cirrhotic Patient.

Authors:  Samuel H Sigal; Zachary Sherman; Arun Jesudian
Journal:  Hepat Med       Date:  2020-04-14

Review 8.  Hepatocrinology.

Authors:  Sanjay Kalra; Saptarshi Bhattacharya; Pawan Rawal
Journal:  Med Sci (Basel)       Date:  2021-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.